Madrigal Pharmaceuticals, Inc. earnings per share and revenue

MDGL earnings per share for the last quarter are -5.68 USD whereas the estimation was -5.24 USD which accounts for -8.42% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -6.22 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MDGL earnings per share and revenue dynamics.